Class D beta-lactamase in complex with beta-lactam antibiotic Descriptor: (2~{S},3~{R})-3-methyl-2-[(2~{S},3~{R})-3-oxidanyl-1-oxidanylidene-butan-2-yl]-4-[(3~{S},5~{S})-5-[(sulfamoylamino)meth yl]pyr
Technological advancements in the North America Beta-lactam and Beta-lactamase Inhibitors industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emergi
Novel beta-lactam/beta-lactamase inhibitor combinations show limited activityagainst Indian Pseudomonas aeruginosa isolates due to conundrum of diverseresistance mechanisms
The Beta-lactam and Beta-lactamase Inhibitors report features an extensive regional analysis, identifying market penetration levels across major geographic areas. It highlights regional growth trends